Eleven Biotherapeutics Lands $35,000,000 Series A Round

  • Feed Type
  • Date
    2/17/2010
  • Company Name
    Eleven Biotherapeutics
  • Mailing Address
    790 Memorial Drive Cambridge, MA 02139
  • Company Description
    Eleven Biotherapeutics is focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics to improve human health and treat disease.
  • Website
    http://www.elevenbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $35,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The money and brainpower is being channeled into a company that seeks to engineer proteins with ideal properties for treating autoimmune diseases and blood clotting disorders.
  • M&A Terms
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.